International Stem Cell Corp (ISCO)
0.09
0.00 (0.00%)
USD |
OTCM |
May 24, 16:00
International Stem Cell Shareholders Equity (Quarterly): -4.264M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -4.264M |
December 31, 2023 | -4.187M |
September 30, 2023 | -3.859M |
June 30, 2023 | -3.846M |
March 31, 2023 | -4.446M |
December 31, 2022 | -4.52M |
September 30, 2022 | -4.652M |
June 30, 2022 | -4.418M |
March 31, 2022 | -4.506M |
December 31, 2021 | -4.588M |
September 30, 2021 | -4.357M |
June 30, 2021 | -4.31M |
March 31, 2021 | -4.698M |
December 31, 2020 | -4.333M |
September 30, 2020 | -3.876M |
June 30, 2020 | -3.605M |
March 31, 2020 | -2.843M |
December 31, 2019 | -2.888M |
September 30, 2019 | -0.676M |
June 30, 2019 | -1.191M |
March 31, 2019 | 3.186M |
December 31, 2018 | 2.537M |
September 30, 2018 | 2.786M |
June 30, 2018 | 1.643M |
March 31, 2018 | 1.639M |
Date | Value |
---|---|
December 31, 2017 | 2.064M |
September 30, 2017 | -0.186M |
June 30, 2017 | 1.593M |
March 31, 2017 | 0.638M |
December 31, 2016 | 3.444M |
September 30, 2016 | 0.425M |
June 30, 2016 | -0.982M |
March 31, 2016 | -12.85M |
December 31, 2015 | 1.594M |
September 30, 2015 | 0.834M |
June 30, 2015 | 0.805M |
March 31, 2015 | -0.079M |
December 31, 2014 | 0.321M |
September 30, 2014 | -0.846M |
June 30, 2014 | -0.365M |
March 31, 2014 | -4.337M |
December 31, 2013 | -4.223M |
September 30, 2013 | -4.403M |
June 30, 2013 | -1.419M |
March 31, 2013 | 0.28M |
December 31, 2012 | -1.758M |
September 30, 2012 | 0.211M |
June 30, 2012 | 1.639M |
March 31, 2012 | 3.669M |
December 31, 2011 | 3.623M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-4.698M
Minimum
Mar 2021
-0.676M
Maximum
Sep 2019
-3.803M
Average
-4.287M
Median
Shareholders Equity (Quarterly) Benchmarks
AIM ImmunoTech Inc | 4.826M |
Perspective Therapeutics Inc | 229.89M |
Protalix BioTherapeutics Inc | 29.79M |
Electromed Inc | 42.54M |
Armata Pharmaceuticals Inc | -56.51M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 5.369M |
Total Liabilities (Quarterly) | 9.633M |
Debt to Equity Ratio | -0.8185 |
Current Ratio | 0.7235 |
Net Debt Paydown Yield | -4.02% |